Neogen (NEOG) Cash from Investing Activities Growth (1y) (2011 - 2026)
Neogen (NEOG) Cash from Investing Activities Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -15.64% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -514.42% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -87.14% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -73.71% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -12.26% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 618.55% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 48.43% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 91.33% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 0.00% |
| 10 | Neogen | 2.61 Bn | 2.42 Bn | 107.80 Mn | 74.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 74.84% |
| Feb 28, 2026 | 64.42% |
| Nov 30, 2025 | 31.99% |
| Aug 31, 2025 | 390.31% |
| May 31, 2025 | 9.29% |
| Feb 28, 2025 | -121.90% |
| Nov 30, 2024 | -248.73% |
| Aug 31, 2024 | -287.63% |
| May 31, 2024 | -354.84% |
| Feb 29, 2024 | -174.98% |
| Nov 30, 2023 | -87.60% |
| Aug 31, 2023 | -110.64% |
| May 31, 2023 | 140.21% |
| Feb 28, 2023 | 226.89% |
| Nov 30, 2022 | 336.42% |
| Aug 31, 2022 | 421.32% |
| May 31, 2022 | 46.08% |
| Feb 28, 2022 | 74.74% |
| Nov 30, 2021 | -272.56% |
| Aug 31, 2021 | 28.90% |